Fig. 2.
Association of IL33 expression with 5-year overall survival.
IHC analysis showed that 44 patients had high IL33 expression and the other 28 patients had low IL33 expression. The overall survival was 57.1% (16/28) in patients with low IL33 expression, which was remarkably lower than that in patients with high IL33 expression (81.8%, 36/44, p < 0.01).